Ketamine Completed Phase 3 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks